Creatine Is Not Just for Young Athletes Building Muscle. Its Most Compelling Evidence Is in Adults Over 55.

The sports nutrition conversation around creatine focuses almost entirely on young athletes seeking performance gains. The most clinically significant benefits of creatine supplementation — slowing sarcopenia, preserving cognitive function, and reducing fall risk — are in adults over 55, and the evidence is more consistent than the performance literature.

---

Sarcopenia: The Slow Emergency

Sarcopenia is the progressive loss of skeletal muscle mass and function with aging. The timeline:

• Muscle mass loss begins gradually after age 30: 3–5% per decade
• Accelerates after age 60–65: 1–2% per year in active adults, faster in sedentary populations
• By age 80, most individuals have lost 30–40% of peak muscle mass relative to their young-adult baseline

The consequences extend beyond physical performance: sarcopenia is independently associated with metabolic syndrome, insulin resistance, increased fracture risk, cardiovascular mortality, and — critically — all-cause mortality. Grip strength at age 50–65 is a stronger predictor of 10-year survival than blood pressure, cholesterol, or BMI in multiple large cohort studies.

The primary drivers of sarcopenic decline: 1. Anabolic resistance: aged muscle is less responsive to the same protein and exercise stimuli that drive hypertrophy in young adults — requiring higher leucine doses and greater mechanical tension to achieve the same MPS response 2. Motor unit remodelling: Type II fast-twitch motor units are preferentially lost with age; remaining motor units are larger but less responsive 3. Phosphocreatine (PCr) system decline: resting intramuscular PCr concentration and creatine kinase activity both decrease with age, impairing rapid ATP regeneration for power-dependent movements

---

Creatine and Aging Muscle: The Evidence

A 2014 meta-analysis by Lanhers et al. and the landmark work of Gualano and colleagues at the University of São Paulo provide the most comprehensive evidence base for creatine in older adults:

Gualano et al. (2014) examined creatine supplementation (5g/day) combined with resistance training versus resistance training alone in older adults (60–80 years) over 12 weeks. Key findings:

• Creatine group gained significantly more lean mass (average 1.4 kg vs 0.8 kg)
• Greater type II muscle fibre cross-sectional area increase
• Better preservation of myosin heavy chain IIX expression — the fast-twitch isoform that is preferentially lost with normal aging
• No adverse effects on renal function despite the age group

The mechanism: creatine loading restores the depleted intramuscular PCr pool in aged muscle, enabling greater work capacity per resistance training session (more total volume completed) and improving acute post-exercise satellite cell activation.

Brose et al. (2003) found that creatine supplementation in older adults increased lean body mass and improved lower-extremity strength at a rate 20–30% above resistance training alone.

A 2017 systematic review by Devries and Phillips (*Nutrients*) synthesising 22 RCTs concluded: *"Creatine supplementation during resistance exercise training is an effective strategy to augment gains in muscle strength and endurance in older adults."*

---

The Cognitive Protection Evidence

Beyond muscle, creatine's role in cognitive function in aging populations is an emerging and important literature:

• Cerebral phosphocreatine availability declines with age, reducing the brain's capacity for rapid ATP regeneration under cognitive demand
• A 2003 study by Rae et al. found creatine supplementation improved working memory in vegetarians (who have lower baseline creatine levels)
• More recently, McMorris et al. (2007) demonstrated creatine supplementation attenuated the cognitive performance decline under sleep deprivation — a model relevant to masters athletes managing sleep disruption
• Emerging evidence links creatine to neuroprotection in Parkinson's, depression, and mild cognitive impairment — though causality in long-term disease prevention is not yet established

---

Dosing Protocol for Masters Athletes

For adults over 55, the evidence-based protocol differs slightly from the athletic loading approach:

Maintenance dose (no loading phase): 3–5g/day indefinitely

• Loading phase (20g/day for 5–7 days) is optional — it achieves saturation faster but produces the same long-term outcome
• Older adults who find loading-phase GI discomfort problematic can go directly to maintenance dose; full saturation is reached within 3–4 weeks

Timing: Creatine timing matters less than daily consistency. Post-exercise may offer marginal benefit for muscle uptake during the post-workout insulin-sensitive window.

Form: Creatine monohydrate remains the most studied and least expensive form. No superior alternative form has demonstrated consistently greater efficacy in peer-reviewed literature.

Safe with long-term use: Multiple long-term studies (up to 5 years) in adults with and without renal considerations show no adverse renal outcomes from 3–5g/day in healthy individuals.

For masters athletes calculating creatine supplementation protocols — including loading versus gradual saturation approaches and maintenance dose targets — the creatine loading calculator at winsport.uk/tools/nutrition/creatine-loading-calculator models both loading and maintenance phases with bodyweight-adjusted dosing, showing the timeline to full PCr saturation under each protocol.

Do you currently prescribe creatine supplementation to masters athletes as a sarcopenia prevention strategy — or does it remain primarily a recommendation for younger competitive athletes in your practice?